Transactivation of fetal liver kinase-1/kinase-insert domain-containing receptor by lysophosphatidylcholine induces vascular endothelial cell proliferation

Endocrinology

Volumn 147, Issue 3, 2006, Pages 1377-1385

  Fujita, Yoshiko ^a   Yoshizumi, Masanori ^a   Izawa, Yuki ^a   Ali, Nermin ^a   Ohnishi, Hideki ^a   Kanematsu, Yasuhisa ^a   Ishizawa, Keisuke ^a   Tsuchiya, Koichiro ^b   Tamaki, Toshiaki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 [(4' CHLORO 2' FLUORO)PHENYLAMINO] 6,7 DIMETHOXYQUINAZOLINE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; [3 (3,5 DIISOPROPYL 4 HYDROXYPHENYL) 2 [(3 PHENYL N PROPYL)AMINOCARBONYL] ACRYLONITRILE]; HERBIMYCIN A; LYSOPHOSPHATIDYLCHOLINE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; TETRAZOLIUM; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSACTIVATION; WESTERN BLOTTING;

ATHEROSCLEROSIS; BENZOQUINONES; BLOTTING, WESTERN; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CINNAMATES; DISEASE PROGRESSION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LACTAMS, MACROCYCLIC; LIGANDS; LYSOPHOSPHATIDYLCHOLINES; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN-TYROSINE KINASES; PYRIMIDINES; QUINAZOLINES; QUINONES; TRANS-ACTIVATION (GENETICS); TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 32644452665     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2005-0644     Document Type: Article

References (41)

1. Kugiyama K, Sugiyama S, Ogata N, Oka H, Doi H, Ota Y, Yasue H 1999 Burst production of superoxide anion in human endothelial cells by lysophosphatidylcholine. Atherosclerosis 143:201-204
2. Kume N, Cybulsky MI, Gimbrone M-J 1992 Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 90:1138-1144
3. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD 1990 Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 344:160-162
4. Tokumura A, Nishioka Y, Yoshimoto O, Shinomiya J, Fukuzawa K 1999 Substrate specificity of lysophospholipase D which produces bioactive lysophosphatidic acids in rat plasma. Biochim Biophys Acta 1437:235-245
5. Caplan BA, Schwartz CJ 1973 Increased endothelial cell turnover in areas of in vivo Evans Blue uptake in the pig aorta. Atherosclerosis 17:401-417
6. Ross R 1999 Atherosclerosis - an inflammatory disease. N Engl J Med 340:115-126
7. Kume N, Gimbrone Jr MA 1994 Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest 93:907-911
8. + channels contributes to ROS-dependent proliferation of cultured human endothelial cells. J Mol Cell Cardiol 36:675-682
9. Zhu K, Baudhuin LM, Hong G, Williams FS, Cristina KL, Kabarowski JH, Witte ON, Xu Y 2001 Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. J Biol Chem 276:41325-41335
10. Kabarowski JH, Zhu K, Le LQ, Witte ON, Xu Y 2001 Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science 293:702-705
11. Soga T, Ohishi T, Matsui T, Saito T, Matsumoto M, Takasaki J, Matsumoto S, Kamohara M, Hiyama H, Yoshida S, Momose K, Ueda Y, Matsushime H, Kobori M, Furuichi K 2005 Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. Biochem Biophys Res Commun 326:744-751
12. i signaling. J Biomed Sci 9:327-333
13. Asakura M, Kitakaze M, Takashima S, Liao Y, Ishikura F, Yoshinaka T, Ohmoto H, Node K, Yoshino K, Ishiguro H, Asanuma H, Sanada S, Matsumura Y, Takeda H, Beppu S, Tada M, Hori M, Higashiyama S 2002 Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat Med 8:35-40
14. Gschwind A, Prenzel N, Ullrich A 2002 Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation. Cancer Res 62:6329-6336
15. Tanimoto T, Lungu AO, Berk BC 2004 Sphingosine 1-phosphate transactivates the platelet-derived growth factor β receptor and epidermal growth factor receptor in vascular smooth muscle cells. Circ Res 94:1050-1058
16. Shah BH, Farshori MP, Jambusaria A, Catt KJ 2003 Roles of Src and epidermal growth factor receptor transactivation in transient and sustained ERK1/2 responses to gonadotropin-releasing hormone receptor activation. J Biol Chem 278:19118-19126
17. Tanimoto T, Jin ZG, Berk BC 2002 Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1/KDR is involved in sphingosine 1-phosphate-stimulated phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS). J Biol Chem 277:42997-43001
18. Ushio-Fukai M, Griendling KK, Becker PL, Hilenski L, Halleran S, Alexander RW 2001 Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21:489-495
19. Yang CM, Lin MI, Hsieh HL, Sun CC, Ma YH, Hsiao LD 2005 Bradykinin-induced p42/p44 MAPK phosphorylation and cell proliferation via Src, EGF receptors, and PI3-K/Akt in vascular smooth muscle cells. J Cell Physiol 203:538-546
20. 2+ level in Jurkat T cell line. Immunol Lett 91:17-21
21. Rikitake Y, Kawashima S, Takahashi T, Ueyama T, Ishido S, Inoue N, Hirata K, Yokoyama M 2001 Regulation of tyrosine phosphorylation of PYK2 in vascular endothelial cells by lysophosphatidylcholine. Am J Physiol Heart Circ Physiol 281:266-274
22. Kyaw M, Yoshizumi M, Tsuchiya K, Kagami S, Izawa Y, Fujita Y, Ali N, Kanematsu Y, Toida K, Ishimura K, Tamaki T 2004 Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation. Mol Pharmacol 65:832-841
23. Yoshizumi M, Tsuchiya K, Kirima K, Kyaw M, Suzaki Y, Tamaki T 2001 Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells. Mol Pharmacol 60:656-665
24. Suzuma K, Naruse K, Suzuma I, Takahara N, Ueki K, Aiello LP, King GL 2000 Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells. J Biol Chem 275:40725-40731
25. Wu LW, Mayo LD, Dunbar JD, Kessler KM, Baerwald MR, Jaffe EA, Wang D, Warren RS, Donner DB 2000 Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation. J Biol Chem 275:5096-5103
26. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, Ullrich A 1999 EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402:884-888
27. Koh JS, Wang Z, Levine JS 2000 Cytokine dysregulation induced by apoptotic cells is a shared characteristic of murine lupus. J Immunol 165:4190-4201
28. Lusis AJ 2000 Atherosclerosis. Nature 407:233-241
29. Rikitake Y, Hirata K, Yamashita T, Iwai K, Kobayashi S, Itoh H, Ozaki M, Ejiri J, Shiomi M, Inoue N, Kawashima S, Yokoyama M 2002 Expression of G2A, a receptor for lysophosphatidylcholine, by macrophages in murine, rabbit, and human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 22:2049-2053
30. Murakami N, Yokomizo T, Okuno T, Shimizu T 2004 G2A is a proton-sensing G-protein-coupled receptor antagonized by lysophosphatidylcholine. J Biol Chem 279:42484-42491
31. Ludwig MG, Vanek M, Guerini D, Gasser JA, Jones CE, Junker U, Hofstetter H, Wolf RM, Seuwen K 2003 Proton-sensing G-protein-coupled receptors. Nature 425:93-98
32. Wells IC, Peitzmeier G, Vincent JK 1986 Lecithin: cholesterol acyltransferase and lysolecithin in coronary atherosclerosis. Exp Mol Pathol 45:303-310
33. Inoue M, Itoh H, Ueda M, Naruko T, Kojima A, Komatsu R, Doi K, Ogawa Y, Tamura N, Takaya K, Igaki T, Yamashita J, Chun TH, Masatsugu K, Becker AE, Nakao K 1998 Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 98:2108-2116
34. Parsons JT, Parsons SJ 1997 Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways. Curr Opin Cell Biol 9:187-192
35. Bernatchez PN, Allen BG, Gelinas DS, Guillemette G, Sirois MG 2001 Regulation of VEGF-induced endothelial cell PAF synthesis: role of p42/44 MAPK, p38 MAPK and PI3K pathways. Br J Pharmacol 134:1253-1262
36. O'Brien ER, Garvin MR, Dev R, Stewart DK, Hinohara T, Simpson JB, Schwartz SM 1994 Angiogenesis in human coronary atherosclerotic plaques. Am J Pathol 145:883-894
37. Kogure K, Nakashima S, Tsuchie A, Tokumura A, Fukuzawa K 2003 Temporary membrane distortion of vascular smooth muscle cells is responsible for their apoptosis induced by platelet-activating factor-like oxidized phospholipids and their degradation product, lysophosphatidylcholine. Chem Phys Lipids 126:29-38
38. Lin P, Ye RD 2003 The lysophospholipid receptor G2A activates a specific combination of G proteins and promotes apoptosis. J Biol Chem 278:14379-14386
39. Heinloth A, Heermeier K, Raff U, Wanner C, Galle J 2000 Stimulation of NADPH oxidase by oxidized low-density lipoprotein induces proliferation of human vascular endothelial cells. J Am Soc Nephrol 11:1819-1825
40. Tokumura A, Majima E, Kariya Y, Tominaga K, Kogure K, Yasuda K, Fukuzawa K 2002 Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as a autotoxin, a multifunctional phosphodiesterase. Biol Chem 277:39436-39442
41. Tokumura A, Harada K, Fukuzawa K, Tsukatani H 1986 Involvement of lysophospholipase D in the production of lysophosphatidic acid in rat plasma. Biochim Biophys Acta 875:31-38